Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza Vaccine Responses in Melanoma Treatment
NCT03315975Phase 4Active, not recruiting
- Sponsor
- University of Pennsylvania
- Start
- Oct 2017
- Primary completion
- Jul 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Fluzone Trivalent in influenza, sponsored by University of Pennsylvania. Started Oct 2017; status: active, not recruiting.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03315975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03315975.